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Despite the increasing use of home blood pressure monitoring (HBPM) in daily practice and the growing awareness in the scientific community about its positive impact on the diagnostic and therapeutic management of patients with high blood pressure (BP), the potential advantages offered by HBPM have not yet been fully exploited. Indeed, use of the information offered by HBPM is often incomplete and imprecise, with the BP values reported by patients in handwritten logbooks being frequently inaccurate, illegible to physicians, or unreliable. Although a practical solution for improvement may come from the use of devices equipped with a storage memory, a step forward in this regard has been taken more recently with the introduction and refinement of systems for the remote telemonitoring of BP values measured at home. However, although several studies have provided evidence on the clinical usefulness of HBPM, only limited data are available on the clinical impact of home blood pressure (HBP) telemonitoring, because of a number of reasons. First, most of the available studies are characterized by a small sample size, and in some cases, the patients were neither randomized nor even matched with a control group. Moreover, technological solutions used in the different studies carried out so far are often heterogeneous, some of them being particularly difficult to use for the patients, thus limiting the effectiveness of the results. BP monitoring programmes, number of BP readings and transmission schedules are often different among the various studies. In addition, patient selection criteria are different from study to study. Finally, different study objectives and important diversities in the types of centres involved (ranging from general practices, to specialists' offices, hospitals or university centres) may have also influenced the quality of results. Large-scale randomized controlled studies, based on easy-to-use technologies, are thus still needed to show the superiority and clinical usefulness of HBP telemonitoring as compared with conventional HBPM. This study summarizes the evidence available on the clinical usefulness and current limitations of this approach, highlighting the results of meta-analyses and randomized controlled trials on this issue. The role of HBP teletransmission in the context of integrated patients' management programmes is also addressed, with indications for further progress in this field. 
Introduction
Over the last 20 years, home blood pressure monitoring (HBPM) has been characterized by a rapid and large diffusion worldwide, with this approach being readily accepted in most cases by both general practitioners and patients. A number of factors have favoured its increasing adoption in daily practice, including technical progress in this field with wider availability of accurate HBPM devices, increasing awareness of the importance of regular out-of-office blood pressure (BP) measurements among both doctors and patients, and progressive acknowledgement of the usefulness of HBPM by international hypertension management guidelines [1] [2] [3] [4] .
At present, approximately 70% of hypertensive patients regularly assess their BP at home [5, 6] and this technique has been recognized as useful for hypertension management by approximately 60% of the general practitioners in North America and by approximately 90% of them in Europe [7, 8] .
However, despite its increasing use in daily practice and the growing awareness in the scientific community about its positive impact on the diagnostic and therapeutic management of patients with high BP, the potential advantages offered by HBPM have not yet been fully exploited. Indeed, use of the information offered by HBPM is often incomplete and imprecise because of problems in the practical implementation of this approach. BP values reported by patients in handwritten logbooks are frequently inaccurate and/or illegible to physicians who, in the short time usually available during consultation, are often unable to obtain a reliable assessment of the average home blood pressure (HBP) characterizing their patient throughout the monitoring period. Given the evidence that prediction of outcome in hypertension is closely related to average BP levels prevailing in the patients' daily life [3] , these difficulties seem to have a negative impact on the effective implementation of HBPM in routine practice. Moreover, imprecise and nonstructured reporting of home measured BP values often does not allow us to obtain a detailed quantification of BP changes induced by treatment and a precise assessment of the degree of out-of-office BP control during follow-up.
According to the studies comparing automatically stored BP readings by memory-equipped devices with logbook manual entries, the under-reporting (omission) of readings by patients may vary between 2 and 35%, overreporting (addition of never measured values) between 7 and 9%, whereas precision (i.e. correspondence between the reported values and values stored by the device) may range from 68 to 76% only [9] [10] [11] . Unfortunately, patients sometimes fail to even show their HBP records to doctors. A recent Japanese study performed in 325 treated hypertensive patients reported that approximately 37% of them did not report HBP measured values to their doctors, and this was more frequently observed in the case of younger patients, in patients with higher systolic BP values, and in those taking a higher number of antihypertensive drugs [12] .
Despite these difficulties, physicians should not be discouraged from using HBPM in clinical decisionmaking, based on the observed clinical advantages associated with this approach, at least when the procedures recommended in the current guidelines are followed [3, 4, 13] . Improvement is needed in this field, however, and this may be achieved through the use of devices equipped with a storage memory and with simple analysis functions, such as calculation of averages over the monitoring period. However, this approach is also not free from limitations, among which is the need for physicians to devote some extra time to BP downloading during consultation, and for patients to regularly bring the memory-equipped device to the doctor's office at the time of each visit. Additional problems may arise from the common practice by patients to use the same memory-equipped device to measure HBP in other family members or even in neighbours. Unless multiple storage memories are available, this may undermine the reliability of the BP values downloaded at the time of consultation because of the risk of storing and averaging BP values of different individuals in the same device.
Most of these problems may be successfully addressed by the recent introduction of systems for the remote telemonitoring of BP values self-measured by patients at home.
Home blood pressure telemonitoring: background and terminology
The development of BP telemonitoring systems was stimulated by the need for increasing the diffusion and the reliability of HBPM in clinical practice. HBP telemonitoring can broadly be considered as a branch or specific application of telemedicine, whose goals include the remote monitoring of main vital and nonvital parameters, usually at the patient's living site [14] . More strictly, patient telemonitoring could be defined as an automatic data transmission process aimed at collecting information on the patient's health status from the point of care to be transmitted to the doctor's office. The main general task of telemonitoring is to provide home healthcare services to patients and to improve disease management by doctors. Thanks to the latest technologies, it is now possible to remotely monitor a large number of clinically relevant parameters, including BP, heart rate, cardiac rhythm, heart sounds, respiratory rate, respiratory function (through home spirometry) and sounds, pulse oximetry, body temperature, body weight, blood parameters (blood glucose and cholesterol, prothrombin time, etc.), physical activity level and duration, compliance to treatment, dietary habits, electroencephalographic signals, and even uterine activity (foetal monitoring) and intraocular pressure.
HBP telemonitoring is generally based on the use of electronic automated BP monitors that store BP values obtained at the patient's home and transfer them to a remote computer through a telephone line (wired or wireless), a modem [15] [16] [17] [18] [19] [20] or an Internet connection [21] . Several systems are available on the market, which are characterized by the different modalities of data collection, transmission and reporting, and by additional features such as reminding facilities for BP measurement to be performed and/or for medication intake, and automatic data reporting. Among the available technologies, wireless systems, at present mostly based on Bluetooth technology, seem to be particularly promising because they are user-friendly and are not limited by the patient's appliances, and they also allow linking the medical devices to the interfaces with built-in mobile telephone-based transmission systems. Remote transmission of relevant clinical data, including BP, and its integration and analysis may lead to automatically generated reports, including graphic display of time variations in the monitored parameters and their averages over the recording period. This may aid the physician in making more appropriate diagnostic and therapeutic decisions, which may also be communicated to the patient without the need for additional clinic visits.
Advantages and limitations
HBP telemonitoring shares most of the advantages of conventional HBPM such as the lack of alarm reaction during the measurement and the potential to obtain several reproducible BP measurements over several days, under daily-life conditions ( Table 1) . As compared with conventional HBPM, it adds the possibility of improving the quality of data reporting and facilitating its interpretation by doctors. Evidence from randomized studies (see below) suggests that HBP telemonitoring may improve BP control and compliance to treatment, and may help in optimising the patient's therapeutic regimen. HBP telemonitoring may in particular be of great advantage to those patients requiring a close follow-up, as in the case of high-risk hypertensive patients.
The main limitation of HBP telemonitoring is the high cost of purchasing and maintaining the system, partly counterbalanced by a reduction in the costs of patients' management compared with usual care. This highlights the importance of a possible reimbursement of HBP telemonitoring by insurance companies and national healthcare systems. Other limitations include the need for user training and the requirement of a telephone or Internet connection, a difficulty that is now partly overcome by recent wireless systems.
Telemonitoring of vital signs: evidence from meta-analyses
In the last few years, meta-analyses of studies based on the application of telemedicine to the remote management of patients with various diseases have shown that telemonitoring of vital signs may be useful in particular settings characterized by severe chronic diseases such as chronic heart failure, chronic respiratory insufficiency, insulin-dependent diabetes mellitus and chronic kidney disease. In contrast, only a few meta-analyses are available to evaluate its clinical usefulness in patients with arterial hypertension, with respect to BP telemonitoring, in particular [22] [23] [24] .
A first meta-analysis by Roine et al. [22] comprising 50 studies performed between 1966 and 2000, has provided a relatively convincing evidence of the effectiveness of telemedicine systems for their application in the fields of teleradiology, teleneurosurgery, telepsychiatry, transmission of echocardiographic images, and in the case of electronic referrals, enabling e-mail consultations and video conferencing between primary and secondary health care providers. In contrast, evidence supporting the usefulness of transtelephonic patient monitoring in hypertension management was relatively weak.
A second meta-analysis included 97 studies carried out between 2000 and 2004. The investigators focused their attention on three distinct areas: store-and-forward, home-based and office/hospital-based services [23] . The areas covered by this meta-analysis were face-to-face clinical specialties, and the analysis was limited to populations covered by Medicare (thus excluding children and pregnant women). The benefits of home-based telemedicine interventions were convincingly shown for chronic diseases only, and by a number of small-sized studies. These interventions seemed to be able to enhance communication with health care providers and favour a closer monitoring of general health care parameters. However, no definitive evidence of a favourable impact on clinical outcome was provided, whereas, at the same time, studies in which these techniques were implemented were conducted in settings requiring additional financial resources and dedicated staff. The investigators concluded that well designed and targeted research, providing high-quality data, is still necessary to clarify whether implementation of technological resources for patients' telemonitoring is really effective in improving disease management and to show how such resources can be best deployed in different health care settings.
More recently, a specific systematic review of studies on home telemonitoring systems in patients with chronic disease has been published [24] . The review included 65 studies carried out between 1990 and 2006, and was focused on the evaluation of the nature and magnitude of the benefit associated with telemonitoring in four types of chronic illnesses: pulmonary conditions, diabetes, arterial hypertension, and cardiovascular diseases. The assessment of the magnitude and significance of the impact of telemonitoring on patients' conditions (e.g. early detection of symptoms, decrease in BP, adequate medication, reduced mortality) was inconclusive for all four chronic illnesses. However, the telemonitoring effects on clinical effectiveness outcomes (e.g. decrease in number of emergency visits, hospital admissions, average length of hospital stay) were consistent and significant in the studies on pulmonary and cardiac patients, but not in the studies focussing on diabetes and hypertension. Despite the limited evidence provided on the usefulness of chronic patients' telemonitoring in terms of clinical outcomes, this recent meta-analysis pointed-out an interesting aspect of this approach. Regardless of their nationality, socioeconomic status, or age, patients showed a high degree of compliance with telemonitoring programmes and regular use of these technologies. This aspect was particularly true for the telemonitoring of BP, probably because of the greater predisposition of hypertensive patients to use electronic BP monitors at home. This finding is supported by the results of a detailed review performed by us on the main studies currently available on such issues, which shows a very high patients' compliance with BP telemonitoring schedules, and a high degree of acceptability of these techniques by both patients and their doctors ( Table 2) .
As summarized and discussed in the next paragraphs, the actual usefulness of BP telemonitoring in hypertension management has been recently addressed by large-scale randomized, prospective controlled studies. Some of these studies are still ongoing, with their results being expected to be published in the forthcoming years.
Evidence from randomized controlled clinical trials
A number of studies have evaluated the efficacy of BP telemonitoring as compared with usual care, according to a randomized design, but very few of them were adequately powered, included a control group, or followed up patients for a reasonable period of time. Whenever a control group was available, evidence of a more pronounced BP reduction in patients randomized to active telemonitoring-based management, compared with those randomized to usual care based on office visits only, was provided. The main characteristics of the most relevant randomized controlled studies, with description of the type of interventions used, are summarized in Table 3 . The main results of these studies are reported and discussed in the next paragraphs.
In one of the first randomized controlled studies [25] , 267 hypertensive patients under the care of community physicians were randomized to HBPM with an interactive telephone reporting system or to usual care, and were included in a 6-month follow-up. Patients measured their own HBP on a weekly basis and reported the results through the computerized telephone system. A significant benefit from the intervention in terms of diastolic BP reduction was observed, after adjustment for baseline between-group differences. No such benefit was conversely seen for systolic BP. Rogers et al. [29] studied 121 hypertensive patients recruited from a hospital clinic. In the intervention group, treatment was based on automated HBP readings transmitted to the study centre through the telephone, whereas in the control group, treatment was based on conventional BP measurements taken during clinic visits only. At the end of the follow-up, a small but significant difference (3 mmHg) in the treatment-induced reduction of 24 h mean ambulatory BP was observed between the intervention group and the control group, in favour of the former. This result remained significant after adjustments for baseline differences between groups.
More recently, larger and adequately powered randomized trials have been performed on this issue, aimed at exploring more accurately whether HBP telemonitoring may indeed be a promising approach to patients' management, by focussing in particular on its ability to produce accurate and reliable data, to influence patients' attitudes and behaviours, and to potentially improve their medical conditions. These studies are described in more detail below. The TeleBPCare study [37] was an open label, randomized, parallel group, controlled study which involved 12 Italian general practices and 298 uncontrolled treated or untreated hypertensive patients. Patients were randomized to either usual care based on office BP measurements or to an integrated care based on HBP values teletransmitted by a device with a built-in modem connected to the patient's telephone line. Twenty-fourhour ambulatory BP monitoring was performed at baseline and after a 6-month follow-up, during which treatment was optimized according to either office or HBP values, respectively, depending on the randomization group. The percentage of daytime BP normalization was significantly higher in the group performing HBP telemonitoring (Fig. 1) ; in this group, there were also less frequent patients' initiated treatment changes (9 vs. 14%, P < 0.05), quality of life tended to be higher and overall management costs lower than in the group randomized to usual care.
The Informatics for Diabetes and Education Telemedicine Study [38, 44, 45] was another recently published large, randomized trial carried out in 1665 Medicare patients with diabetes mellitus, aged 55 years or above, and living in medically underserved areas of the New York State. Patients were randomized to usual care by their primary care providers or to telemonitoring, based on a home telemedicine unit consisting of a web-enabled computer with modem connection to the patient's telephone line. The unit provided four major functions: videoconferencing with a nurse, remote monitoring of glucose and BP with electronic data upload and link to a web portal providing access to the patient's own clinical data and secure web-based messaging with nurse case managers. The primary endpoints were control of HbA1c, BP, and low-density lipoprotein (LDL) cholesterol levels. As shown in Fig. 2 , in the intervention group, mean HgbA1c, BP, and LDL cholesterol improved over 1 year significantly more than in the usual care group. The differences between the usual care and the intervention groups were confirmed after a 5-year follow-up, with a significant reduction (P < 0. [44] . A satisfaction survey among the intervention group participants (n = 346) and among the participating primary care physicians (n = 116) showed high levels of satisfaction with the major intervention components and a positive perceptions for acceptability of the telemonitoring system, its impact on patients and communication between patient and physician [45] . Although this study showed that telemonitoring of BP may improve BP control in diabetic patients, it failed to show a positive impact on long-term mortality and cost saving, probably because the study power was limited in this regard. Indeed, the difference HbA1c, systolic and diastolic blood pressure (BP) and low density lipoprotein cholesterol (LDL-C) values at the 1-year follow-up in diabetic patients randomized to usual care (control group, open bars) or to home blood pressure telemonitoring (HBPT, striped bars). Data are shown as means ± standard deviation. P refers to the statistical significance of the between-groups differences (modified with permission from [38] ).
in mortality between the intervention (176 deaths) and the usual care groups [169 deaths, hazard ratio 1.01 (95% confidence interval 0.82-1.24)] was not statistically significant [38] . Total costs were between 71 and 116% higher in the intervention group than in the control group, amounting to $ 8000 per person per year in the intervention group [45] .
The telemonitoring and self-management in hypertension trial (TASMINH2) [39] is a primary care-based randomized controlled trial with embedded economic and qualitative analyses to evaluate the costs and effectiveness of increasing patient involvement in BP management, specifically with respect to home monitoring and self titration of antihypertensive medication compared with usual care. Main study results have been published recently. Hypertensive patients (480) were recruited from 24 general practices in the UK: 234 randomized to self-monitoring of BP and self-titration of antihypertensive drugs combined with HBP telemonitoring and 246 to usual care. The primary endpoint was the change in the mean systolic BP between baseline and each follow-up point (6 and 12 months). Secondary outcomes included change in mean diastolic BP, costs, adverse events, health status, illness perceptions, beliefs about medication, compliance with medication and anxiety. At 6 months, the mean systolic BP decreased by 12.9 mmHg in the self-management group and by 9.2 mmHg in the usual care group (P = 0.013). At 12 months, BP reduction in the telemonitoring group was still significantly greater than in the control group (17.6 vs. 12.2 mmHg, P = 0.0004). Secondary endpoints and frequency of most of the sideeffects did not differ between the groups, apart from leg swelling (reported by 32% of patients in the selfmanagement vs. 22% in the control group, P = 0.022).
In the Hypertension Intervention Nurse Telemedicine Study [40] , three different interventions were tested according to a randomized, controlled design using HBP telemonitoring. A sample of 636 hypertensive patients with poor BP control were randomized to usual care, nurse-administered tailored behavioural intervention, and nurse-administered medication management according to a hypertension decision support system, and to the combination of the last two interventions. The interventions had to be triggered based on HBP values transmitted through the telemonitoring devices over standard telephone lines. The tailored behavioural intervention involved promoting adherence to medication prescriptions and healthy behaviours. Patients randomized to the medication management or the combined arms had their hypertension regimen changed by the study team using a validated hypertension decision support system, which was based on evidence-based hypertension treatment guidelines, and properly designed to adapt such guidelines to individual patients' comorbid illnesses. Primary outcome was office BP control: 140/90 mmHg or less in nondiabetic and 130/80 mmHg or less in diabetic patients over 24 months of follow-up. Four hundred and seventy-five patients completed the follow-up, with improvements in the proportion of patients with BP control of 4.3% in the behavioural intervention group, 7.6% in the HBP monitoring group, and 11.0% in the combined intervention group, as compared with the usual care group. As compared with usual care, the 24-month difference in systolic BP was 0.6 mmHg for the behavioral intervention group, -0.6 mmHg for the HBP monitoring group, and -3.9 mmHg for the combined intervention group; the patterns were similar for diastolic BP. In conclusion, according to this study's results, combined HBP monitoring and tailored behavioural telephone intervention were able to improve BP control as compared with usual care.
Thus, only a few randomized, controlled, and prospective studies have been able to show a significantly better BP control when hypertensive patients are followed through HBP telemonitoring systems as compared with standard care. Telemedicine was in particular very effective when combined with regular individualized intervention-like telephone calls. Despite their interest, however, before being translated into clinical recommendations, these data would need to be confirmed by large prospective studies focussing on the 'hard' endpoints and including an assessment of the economic aspects, too. Such studies are difficult to perform, given the high costs of technologies, the decrease in the level of patients' and doctors' adherence to study procedures, the difficulty in objectively assessing endpoints related to economic aspects or quality of life, and the need for a hundred or thousand patients to show minor secondary endpoints. Information of special interest is particularly expected to come from the assessment of the value of remote telemonitoring of high-risk hypertensive patients, such as those with metabolic disorders, coronary artery disease, heart failure, cerebrovascular complications, or pregnancy-associated hypertension. Some of these studies are indeed currently ongoing and will hopefully provide further evidence to clarify the actual clinical usefulness of HBP telemonitoring.
The Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure Study is a 2 Â 3 factorial, prospective, randomized, open-blinded endpoint design study with a hard endpoint represented by a composite of nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death [41] . The study is the first large-scale HBP-based and Internet-connected intervention trial. It started in 2001 and foresees a ollow-up of 7 years. A total of 1953 untreated essential hypertensive patients with elevated HBP values (Z 135/85 mmHg) have been randomized to one of the two HBP target groups: HBP within the range of 134-125/84-80 mmHg, or 125/80 mmHg, or less and to regimens based on initial treatment with one of the three antihypertensive drug classes (calcium-antagonists, angiotensin-converting enzyme-inhibitors or angiotensin II antagonists) [46, 47] . Each patient is asked to measure BP at home with an electronic device: data are downloaded to the outpatient terminal at every clinic visit, and then transmitted to the host computer through the Internet. On the basis of these HBP values, the host computer determines the necessity of additional therapy or dose increments in four further steps to reach the randomized target BP, and then transmits the information to the terminal at the outpatient clinic. Preliminary results [46] of the first year follow-up in this study showed a similar HBP reduction among the treatment groups and between groups with higher or lower BP targets, respectively.
Home blood pressure telemonitoring: models of integrated patients' management and counselling Among the many potential advantages of telemedicine systems in hypertension management, besides BP teletransmission, two are of particular interest. These are the possibility of creating a collaborative care management among the various healthcare providers (i.e. physicians, nurses, pharmacists), and the possibility to facilitate the forwarding of information to patients with the final aim of improving clinical outcomes. As far as BP telemonitoring is concerned, there are two recent experiences in favour of this integrated model of healthcare provision.
An Italian study assessed the impact of the interaction between 60 general practitioners and 23 hospital-based hypertension clinics on the effectiveness of BP and total cardiovascular risk control [42] . The technology used in the study was an Internet-based digital network connecting specialists and general practitioners. By using this web-based system, specialists could be rapidly updated on their patients' conditions. The study population consisted of 1985 patients for whom general practitioners could update records online and 1949 patients referred to the specialist clinics by general practitioners from outside the network, who served as controls. At the end of the 2-year follow-up, the percentage of patients with an office BP normalization (< 140/90 mmHg) was significantly greater in the telemedicine group than in the control group (51 vs. 47%, respectively; P < 0.001). The intervention group also showed a lower rate of fatal and nonfatal major cardiovascular events than the control group (2.9 vs. 4.3%, respectively; P < 0.02). The main study limitations were the comparison with an external control group, and the BP measurement taken in the doctor's office and not at the patient's home on several days.
The Electronic Communications and Home Blood Pressure Monitoring study was a three-arm randomized controlled trial designed to determine whether care based on the Chronic Care Model and delivered over the Internet improves hypertension management [48] . Seven hundred and seventy-eight uncontrolled hypertensive patients receiving care at the Group Health medical centres were randomly assigned to three intervention groups: (i) usual care, (ii) HBP monitoring device assignment and proficiency training on its use, together with the access to the Group Health secure patient website (with secure e-mail access to their healthcare provider, access to a shared medical record, prescription refill and other services) or (iii) the above plus pharmacists' care management (collaborative care management between the patient, the pharmacist, and the patient's physician through a secure patient website and an electronic medical record). As shown in Fig. 3 , among the 730 patients completing the 1-year follow-up, the patients assigned to the HBP monitoring and web training group had a nonsignificant increase in the rate of BP control as compared with usual care, whereas adding web-based pharmacists' care to HBP monitoring and web training significantly increased the percentage of patients with controlled BP [43] . The investigators concluded that pharmacists' care management delivered through secure patient web communications may improve BP control in patients with uncontrolled hypertension. This study, however, suffered from several limitations [49] . First, the patients enrolled were somewhat atypical as compared with the usual patients with hypertension, being younger and with a higher level of education. Second, half of the patients enrolled in the study already owned and regularly used a monitor for self-BP measurement. Finally, the group randomized to BP telemonitoring and web training had the same number of telephone contacts with the physician as the usual care group, with this possibly explaining the very similar rate of BP control in these two groups of the study.
Thus, integrated interventions, based on BP telemonitoring, could be used to improve the care of large numbers of patients with uncontrolled hypertension, but, also in this case, their efficacy and cost-effectiveness need to be further investigated in future large-scale and welldesigned studies.
Home blood pressure monitoring or home blood pressure telemonitoring: which choice?
Given the relatively high costs and the implementation difficulties in the routine use of telemonitoring technologies, patients and doctors may wonder why they should use BP telemonitoring systems rather than the more economical and easier-to-use HBP monitoring devices.
As indirectly shown by some studies, HBP telemonitoring might help in improving BP control and adherence to drug treatment in difficult patients, particularly in those at high risk, such as patients with diabetes or clinically manifest cardiovascular disease. However, evidence of superiority of HBP telemonitoring in such patients, with respect to HBP monitoring without data teletransmission, coming from head-to-head studies is still lacking.
There is, to our knowledge, at present only one study that attempted at comparing the differences in the BP values measured at home with and without teletransmission [35] . The study was based on a very simple technology: the patients performed HBP measurements with electronic devices and then entered these values into an Internet-based telemedicine system. The study was carried out in 464 high-risk patients of an underserved population, who were randomized to a control group (simple HBP monitoring) and a telemedicine group. The study did not compare the BP values measured at home by the two groups, but only the reliability between the data transmitted by the patients and that actually stored in the monitor, which was very high. However, the study showed that more patients randomized to the telemedicine group measured their BP at home (92 vs. 49%), and that only a few of these patients failed to perform any measurement, with most patients meeting or exceeding the suggested weekly rate of HBP readings. This suggests that the teletransmission of HBP values may increase the patient's compliance to the prescribed frequency of BP measurements.
The effects of HBP monitoring, with and without teletransmission facilities, on BP control, adherence to treatment, and target organ damage are currently being compared in an open-label, randomized, controlled study carried out in the Milan area in Italy. This study was started in 2007 and is expected to be concluded by the end of 2010. Two hundred and fifty-two uncontrolled treated or untreated hypertensive patients with metabolic syndrome have been randomized to 12 months of usual care (control group) or to 6 months of HBP telemonitoring followed by 6 months of HBP monitoring without the availability of BP teletransmission facilities between office visits. The aim of this study is to assess the actual superiority of a management approach including the regular implementation of HBP as compared with usual care in improving hypertension control, and to discriminate, in this context, between the effects of HBP monitoring implemented alone or in combination with telemedicine systems for the remote teletransmission of HBP values, on the control of mean daytime ambulatory BP. An additional aim of this study is to evaluate whether the implementation of a relatively short HBP telemonitoring period may indeed favourably affect the patients' compliance with antihypertensive treatment, and whether and for how long such an effect persists over time after the telemonitoring period is over.
This study is also aimed at exploring a specific and important issue, which has often been disregarded by studies on the usefulness of patients' clinical data telemonitoring at home, that is, whether and how much the effectiveness of telemonitoring may depend on the characteristics of the population at hand. It could indeed be hypothesized that patients' age, culture, and education play a role in the effectiveness of any of these interventions. Should this be the case, then some prescreening for the appropriate intervention for a given population might be useful, for example, planning nurse involvement for older patients and more sophisticated technological interventions in the case of younger and better educated patients. As mentioned earlier, some information on the impact of individual patients' characteristics on the effectiveness of a telemedicinebased intervention in the management of patients with chronic diseases comes from a recent meta-analysis [24] . The investigators concluded that, regardless of their nationality, socioeconomic status, or age, most of these chronic patients showed a high degree of compliance with telemonitoring programmes and regular use of these technologies. This was in particular the case for the telemonitoring of BP, probably because of the greater predisposition of hypertensive patients to use electronic BP monitors at home. This conclusion is supported by the results of a detailed review we performed on the main studies currently available on this issue (Table 2) , which shows a very high patients' compliance with BP telemonitoring schedules and a high degree of acceptability of BP telemonitoring procedures by both patients and their doctors, over a wide age and socio economic status range. Perspectives for an even better and wider acceptability of interventions based on home patients' telemonitoring are now offered by the progress in the technological development of tools based on the use of wearable sensors and the ability to offer simple and unobtrusive solutions for home monitoring of the patients' vital parameters over a wide age and education level ranges [50, 51] .
Conclusion
HBP telemonitoring represents a promising technology that has been suggested to help improve the diagnosis and management of hypertension, increase the rate of BP control and at the same time reduce the risk of overmedication in hypertensive patients. At present, the teletransmission of HBP values could be considered a potentially useful complement to conventional HBP monitoring in selected patients, such as those requiring a closer follow-up or those living in remote sites. The positive evaluation of telemedicine technologies given so far by both doctors and patients and the possibility to combine BP monitoring with the monitoring of several vital signs in high-risk patients, may all represent factors favouring a wider diffusion of this technology in the near future. Telemonitoring of BP may finally help in creating a tighter collaboration between doctors and other healthcare providers (e.g. nurses or pharmacists) aimed at improving BP control and, in general, disease management of hypertension. However, before this approach can be recommended in routine clinical practice, additional evidence is still needed. In particular, an important issue still to be adequately addressed is the ratio between the clinical benefits and costs of HBP telemonitoring, and its actual impact on cardiovascular morbidity and mortality of hypertensive patients.
Moreover, a larger field diffusion of this approach would also require further cooperation between health care authorities and technology providers to make access to telemonitoring systems more affordable for both patients and health care providers. This could be greatly facilitated by allowing HBP telemonitoring, even for selected time periods only, to be reimbursed by health care insurances and/or by national health care systems.
